Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

Diabetes Care. 2008 Apr;31(4):811-22. doi: 10.2337/dc08-9018.

Authors

John D Brunzell¹, Michael Davidson, Curt D Furberg, Ronald B Goldberg, Barbara V Howard, James H Stein, Joseph L Witztum; American Diabetes Association; American College of Cardiology Foundation

Affiliation

¹ Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, and the Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA.

PMID: 18375431
DOI: 10.2337/dc08-9018

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Cardiovascular Diseases / blood
Cardiovascular Diseases / epidemiology*
Cardiovascular Diseases / prevention & control
Cholesterol, LDL / blood
Diabetes Mellitus, Type 2 / complications*
Diabetic Angiopathies / blood
Diabetic Angiopathies / epidemiology*
Diabetic Angiopathies / prevention & control
Humans
Lipoproteins / blood*
Lipoproteins / metabolism
Risk Factors
Societies, Medical
United States
Voluntary Health Agencies

Substances

Cholesterol, LDL
Lipoproteins